News
Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt ...
Roche has added a phase 3 trial of trontinemab, hoping to show it can delay or prevent progression to Alzheimer's symptoms in preclinical patients.
See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025.
Servotech Renewable Power System Share Price Today 8 Aug 2025: Track Servotech Renewable Power System share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results